The COVID-19 pandemic has necessitated many novel responses in healthcare including sport and exercise medicine. The cessation of elite sport almost globally has had significant economic implications and resulted in pressure to resume sport in very controlled conditions. This includes protecting pitch-side medical staff and players from infection. The ongoing prevalence of SARS-CoV-2 and the desire to resume professional sport required urgent best practice guidelines to be developed so that sport could be resumed as safely as possible. This set of best practice recommendations assembles early evidence for managing SARS-CoV-2 and integrates expert opinion to provide a uniform and pragmatic approach to enhance on-field and pitch-side safety for the clinician and player. The nature of SARS-CoV-2 transmission creates new hazards during resuscitation and emergency care and procedures. Recommendations for the use and type of personal protective equipment during on-field or pitch-side emergency medical care is provided based on the clinical scenario and projected risk of viral transmission.
- elite performance
- communicable disease
This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Statistics from Altmetric.com
Twitter @drccowie, @drsimonkemp, @dundeesportsmed, @drcraigsheridan, @jonpatricios
Collaborators This position statement is endorsed by: The Football Association UK, The English Rugby Football League, The Scottish Football Association, The English Rugby Football Union, The Lawn Tennis Association, The British Horse Racing Association, The Welsh Rugby Union, English Premiership Rugby, Scottish Rugby, The English Institute of Sport, The Scottish Institute of Sport, Wits Sport and Health, South Africa.
Contributors LH and GP initiated the consensus process, drew up the first draft of the guidance document and convened and led the consensus group. The following coauthors were involved in the submitting of data and protocols, writing of the manuscript and editing each version of both the guidance document and the paper in every round of communication: JG, JoH, JM, PM, AS, MW, CMC, SK, MP, JL, JeH, MR, NE, PB, JP, AP, HS, CS, MH, PR, AB, SC, RT, RH, RW, RJ, SS, MRC and JP. JP served as an external expert opinion, reviewing and editing each draft of the guidance document and the paper, communicating with the lead authors through each iteration, reformatting the guidance document according to the AGREE criteria and drafting the consensus paper. JP initiated the revision of the manuscript with LH and GP with all authors providing additional input with MRC providing the final proof read and expert input.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.